SUFLAVE

Braintree Laboratories, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 15, 2023
Approval ID: 546cfc44-791c-4524-99a9-6a0af96c4ec8
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SUFLAVE safely and effectively. See full prescribing information for SUFLAVE. SUFLAVE (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution) Initial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.